The Mouse Phenotyping Shared Resource (MPSR) was established in 2001 to provide expert, readily available, and affordable experimental pathology support to OSUCCC investigators utilizing animal models of human cancer. The MPSR specializes in the morphologic characterization of newly produced lines of genetically engineered mice, but also provides a variety of other customized pathology services, including necropsy, slide preparation, semi-quantitative histopathology for experimental studies, morphometry, hematology, clinical chemistry, consultation and referral. The MPSR is headed by Donna F. Kusewitt, D.V.M., Ph.D., a board-certified veterinary pathologist and NCI-funded Investigator and staffed by Deborah Devor Henneman, B.S., each with more than 20 years of experience in carcinogenesis and experimental pathology. The MPSR is strongly supported through the excellent veterinary resources (clinical pathology, histology, and immunohistochemistry service) and veterinary pathology expertise (10 board-certified veterinary pathologists) available in the Department of Veterinary Biosciences (VBS) at The Ohio State University (OSU). Since its inception in 2001, the MPSR has provided high quality experimental pathology services tailored to meet the needs of the growing number of OSUCCC investigators who employ animal models of human cancer. During this time, 23 funded CCC members consulted on 38 projects requiring 1,042 hours of MPSR service, representing 75% of its entire workload. The MPSR has also provided requisite information for grant applications and manuscripts for many of OSUCCC members. The volume of work performed in the MPSR has steadily increased since the service was initiated and, given the projected expansion of OSUCCC research programs, a continued increase in MPSR usage is anticipated. Indeed we provide documentation of 37 CCSG-funded investigators with over 40 projects requiring MPSR support in the near future. Finally, the MPSR also serves as an essential venue for training future mouse pathobiologists as part of an NCRRfunded T-32 training grant, """"""""Mouse Pathobiology: Models of Human Disease"""""""".

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-34
Application #
7743480
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2010-11-30
Support Year
34
Fiscal Year
2009
Total Cost
$84,278
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Shu, Yi; Yin, Hongran; Rajabi, Mehdi et al. (2018) RNA-based micelles: A novel platform for paclitaxel loading and delivery. J Control Release 276:17-29
Scoville, Steven D; Nalin, Ansel P; Chen, Luxi et al. (2018) Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood 132:1792-1804
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Schimizzi, Gregory V; Jin, Linda X; Davidson 4th, Jesse T et al. (2018) Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB (Oxford) 20:332-339
Fu, Xinping; Tao, Lihua; Wang, Pin-Yi et al. (2018) Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles. Oncotarget 9:21348-21358
Brewington, Beatrice Y; Shao, Yusra F; Davidorf, Fredrick H et al. (2018) Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions. Clin Ophthalmol 12:925-934
Doogan, Nathan J; Cooper, Sarah; Quisenberry, Amanda J et al. (2018) The role of travel distance and price promotions in tobacco product purchase quantity. Health Place 51:151-157
Byrd, John C; Ruppert, Amy S; Heerema, Nyla A et al. (2018) Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). Blood Adv 2:1705-1718
Oblinger, Janet L; Burns, Sarah S; Huang, Jie et al. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol 299:299-307
Pan, Pan; Oshima, Kiyoko; Huang, Yi-Wen et al. (2018) Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. Int J Cancer 143:886-896

Showing the most recent 10 out of 2602 publications